You just read:

Bayer Receives FDA Approval for Aliqopa™ (copanlisib) 60 mg vial for Injection in Adults with Relapsed Follicular Lymphoma after Two Prior Systemic Therapies

News provided by

Bayer

Sep 14, 2017, 17:10 ET